{"task_id": "6738e15ff47e4a4c", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 869/905)", "text": "edn). Oxford: Oxford University Press; 2016:186\u201395\n\n--- Page 875 ---\n861\nReferences\n8 P\u00e9rez Fidalgo JA, Garc\u00eda Fabregat L, Cervantes A, et al. Management of chemotherapy extravasation: \nESMO\u2013EONS Clinical Practice Guidelines. Ann Oncol 2012; 23(suppl 7): vii167\u2013vii173. https://academic.oup.\ncom/annonc/article/23/suppl_7/vii167/145139/Management-of-chemotherapy-extravasation-ESMO-EONS\n9 Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of \nClinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31(19):2500\u201310. http://ascopubs.org/\ndoi/full/10.1200/JCO.2013.49.2678\n10 Ahmad SS, Duke S, Jena R, et al. Advances in radiotherapy. BMJ 2012; 345e7765. http://www.bmj.com/\ncontent/345/bmj.e7765.long\n11 DeAngelo D, Alyea EP. Oncologic emergencies. In: Singh AK, Loscalzo J (eds) The Brigham Intensive \nReview of Internal Medicine. Oxford: Oxford University Press, 2014:159\u201367\n12 Lee DLY, Anthoney A. Complications of systemic therapy \u2013 gut infections and acute diarrhoea. Clin Med \n14(5):528\u201345. http://www.clinmed.rcpjournal.org/content/14/5/528.full.pdf+html\n13 Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin \nProc 2010; 85(9):838\u201354. http://www.mayoclinicproceedings.org/article/S0025-6196(11)60214-0/abstract\n14 Sturgeon CM, Lai LC, Duff y MJ. Serum tumour markers: how to order and interpret them. BMJ 2009; \n339:b3527. http://www.bmj.com/content/339/bmj.b3527.long\n15 Schr\u00f6der FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: results of the Eu-\nropean Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow up. Lancet 2014; \n384(9959):2027\u201335. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60525-0/abstract\n16 Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell \nlung cancer. N Engl J Med 2010; 363:733\u201342. http://www.nejm.org/doi/full/10.1056/NEJMoa1000678\n17 World Health Organization. Analgesic ladder. http://www.who.int/cancer/palliative/painladder/en/\n18 NHS England. NPSA safety alert: Risk of distress and death from inappropriate doses of naloxone \nin patients on long-term opioid/opiate treatment. 2014. https://www.england.nhs.uk/wp-content/up-\nloads/2014/11/psa-inappropriate-doses-naloxone.pdf\n19 NHS Scotland. Scottish palliative care guidelines. 2014. http://www.palliativecareguidelines.scot.nhs.\nuk/\n20 Universities of Hull, Staff ordshire and Aberdeen. Spiritual care at the end of life: A systematic review. \n2010. https://www.gov.uk/government/uploads/system/uploads/attachment_data/\ufb01 le/215798/dh_123804.\npdf\n21 Kaye P. Spiritual pain. In: Notes on symptom control in hospice and palliative care. Hospice Education \nInstitute. 1990.\n22 Ruegger J, Hodgkinson S, Field-Smith A, et al. Care of adults in the last days of life. BMJ 2015; 351:h6631. \nhttp://www.bmj.com/content/351/bmj.h6631\n23 General Medical Council. Treatment and care towards the end of life. 2010. http://www.gmc-uk.org/\nstatic/documents/content/Treatment_and_care_towards_the_end_of_life_-_English_1015.pdf\nChapter 12: Rheumatology\n1 Doherty M, Dacre J, Dieppe P, et al. The \u2018GALS\u2019 locomotor screen. Ann Rheum Dis 1992; 51:1165\u20139. https://\nwww.ncbi.nlm.nih.gov/pmc/articles/PMC1012427/\n2 Courtney P, Doherty M. Joint aspiration and injection. Best Pract Res Clin Rheumatol 2005; 19:345\u201369. \nhttp://www.bprclinrheum.com/article/S1521-6942(05)00010-0/abstract\n3 Speed C. Low back pain. BMJ 2004; 328:1119\u201321. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC406328/\n4 NICE. Low back pain in adults: Early management [CG88]. 2009. https://www.nice.org.uk/guidance/cg88\n5 Woolf AD, P\ufb02 eger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003; \n81(9):646\u201356. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572542/\n6 Sowers M, Jannausch M, Stein E, et al. C-reactive protein as a biomarker of emergent osteoarthritis. \nOsteoarthritis Cartilage 2002; 10(8):595\u2013601. https://www.ncbi.nlm.nih.gov/pubmed/12479380\n7 NICE. Osteoarthritis: Care and management [CG177]. Available at: https://www.nice.org.uk/guidance/\ncg177\n8 Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the \nknee. Cochrane Database Syst Rev 2006; 2:CD005321. http://onlinelibrary.wiley.com/doi/10.1002/14651858.\nCD005321.pub2/abstract\n9 Garc\u00eda-De La Torre I. Advances in the management of septic arthritis. Rheum Dis Clin North Am 2003; \n29(1):61\u201375. https://www.ncbi.nlm.nih.gov/pubmed/12635500\n10 Ross JJ, Saltzman CL, Carling P, et al. Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis \n2003; 36(3):319\u201327. http://cid.oxfordjournals.org/content/36/3/319.long\n11 Coakley G, Mathews C, Field M, et al. BSR & BHPR, BOA, RCGP and BSAC guidelines for management \nof the hot swollen joint in adults, 2006. Rheumatology (Oxford) 2006; 45(8):1039\u201341. http://rheumatology.\noxfordjournals.org/content/45/8/1039.long\n12 Mathews CJ, Kingsley G, Field M, et al. Management of septic arthritis: a systematic review. Ann Rheum \nDis 2007; 66(4):440\u20135. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856038/\n13 Blizard Institute Clinical Eff ectiveness Group. NSAIDs: Reducing the risk summary guidelines. 2015. \nhttp://www.blizard.qmul.ac.uk/ceg-resource-library/clinical-guidance/clinical-guidelines.html\n14 McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-in\ufb02 ammatory drugs: systematic \nreview of population-based controlled observational studies. PLoS Med 2011; 8(9):e1001098. https://www.\nncbi.nlm.nih.gov/pmc/articles/PMC3181230/\n15 Scarpignato C, Lanas A, Blandizzi C, et al. Safe prescribing of non-steroidal anti-in\ufb02 ammatory drugs \nin patients with osteoarthritis \u2013 an expert consensus addressing bene\ufb01 ts as well as gastrointestinal and \ncardiovascular risks. International NSAID Consensus Group. BMC Med 2015; 13:55. https://www.ncbi.nlm.\nnih.gov/pmc/articles/PMC4365808/\n16 Chan F, Wong VW, Suen BY, et al. Combination of COX-2 and PPI for prevention of recurrent ulcer \nbleeding in patients at very high risk. Lancet 2007; 369:1621\u20136. http://www.thelancet.com/journals/lancet/\narticle/PIIS0140-6736(07)60749-1/abstract\n17 Calg\u00fcneri M, Ureten K, Akif Ozt\u00fcrk M, et al. Extra-articular manifestations of rheumatoid arthritis: \nresults of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 2006; 24(3):305\u20138. http://www.\nclinexprheumatol.org/article.asp?a=2873", "text_length": 6481, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 869/905)", "type": "chunk", "chunk_index": 868, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.683048", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.683921", "status": "complete", "chunks_added": 4}